TY - JOUR
T1 - Expression of neural cell adhesion molecules in the mouse anterior pituitary gland and pituitary tumor cells
AU - Yayoi, Yoshihiro
AU - Takahashi, Sumio
AU - Takeuchi, Sakae
AU - Takeuchi, Makoto
AU - Seki, Tatsunori
AU - Arai, Yasumasa
PY - 1998/8
Y1 - 1998/8
N2 - Neural cell adhesion molecules (NCAMs) were immunocytochemically detected in the pituitary glands of female ICR mice and in the pituitary tumor cell lines (GH3 cells and AtT-20 cells) using the antibody against mouse NCAM. Immunoreactive NCAMs (ir-NCAMs) were detected in the cell membranes of mouse pituitary cells, GH3 cells and AtT-20 cells. Fifty four percent of anterior pituitary cells, 58% of neurointermediate cells (cells of both posterior and intermediate lobes), 13% of GH3 cells and 43% of AtT-20 cells expressed ir-NCAMs. Anterior pituitary cell types of NCAM-expressing cells were identified. Most of somatotrophs, gonadotrophs, and thyrotrophs showed NCAM-immunoreactivity, while parts of mammotrophs and corticotrophs did. The cell-type-specific pattern of NCAM expression in the mouse pituitary may be closely associated with physiological roles of pituitary NCAMs. For clarifying roles of pituitary NCAM, AtT-20 cells were treated with antisense oligodeoxynucleotide (ODN) which was complementary to the translation initiation site of NCAM mRNA, or with sense ODN which corresponded to the sense sequence for 7 days. Antisense ODN treatment (100 nM) decreased the percentage of NCAM-expressing cells, and surprisingly increased the cell number of AtT-20 cells compared with sense ODN treatment and non-treatment. This result suggests that NCAM is involved in the growth control of AtT-20 cells.
AB - Neural cell adhesion molecules (NCAMs) were immunocytochemically detected in the pituitary glands of female ICR mice and in the pituitary tumor cell lines (GH3 cells and AtT-20 cells) using the antibody against mouse NCAM. Immunoreactive NCAMs (ir-NCAMs) were detected in the cell membranes of mouse pituitary cells, GH3 cells and AtT-20 cells. Fifty four percent of anterior pituitary cells, 58% of neurointermediate cells (cells of both posterior and intermediate lobes), 13% of GH3 cells and 43% of AtT-20 cells expressed ir-NCAMs. Anterior pituitary cell types of NCAM-expressing cells were identified. Most of somatotrophs, gonadotrophs, and thyrotrophs showed NCAM-immunoreactivity, while parts of mammotrophs and corticotrophs did. The cell-type-specific pattern of NCAM expression in the mouse pituitary may be closely associated with physiological roles of pituitary NCAMs. For clarifying roles of pituitary NCAM, AtT-20 cells were treated with antisense oligodeoxynucleotide (ODN) which was complementary to the translation initiation site of NCAM mRNA, or with sense ODN which corresponded to the sense sequence for 7 days. Antisense ODN treatment (100 nM) decreased the percentage of NCAM-expressing cells, and surprisingly increased the cell number of AtT-20 cells compared with sense ODN treatment and non-treatment. This result suggests that NCAM is involved in the growth control of AtT-20 cells.
UR - http://www.scopus.com/inward/record.url?scp=0031791225&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031791225&partnerID=8YFLogxK
U2 - 10.2220/biomedres.19.269
DO - 10.2220/biomedres.19.269
M3 - Article
AN - SCOPUS:0031791225
VL - 19
SP - 269
EP - 277
JO - Biomedical Research
JF - Biomedical Research
SN - 0388-6107
IS - 4
ER -